| Product name | Trametinib |
| CAS NO. | 871700-17-3 |
| Synonyms | (GSK1120212) |
| Category | Pharmaceutical Raw Materials,Active Pharmaceutical Ingredients,Bulk Drugs,Fine Chemicals. |
| Purity | 99% Trametinib |
| Appearance | Trametinib powder |
| Shelf life | 2 years |
| Usage | Trametinib is an anti-cancer drug. |
| Storage | Trametinib should be stored in a well-closed container at low temperature, keep away from moisture, heat and light. |
| Note | Trametinib for R&D use only. |
Function
Trametinib, also known as GSK1120212, is a n orally bioavailable inhibitor of mitogen-activated protein kinase kinase (MEK
MAPK/ERK kinase) with potential antineoplastic activity. Trametinib specifically binds to and inhibits MEK 1 and 2, resulting in
an inhibition of growth factor-mediated cell signaling and cellular proliferation in various cancers. MEK 1 and 2, dual
specificity threonine/tyrosine kinases often upregulated in various cancer cell types, play a key role in the activation of the
RAS/RAF/MEK/ERK signaling pathway that regulates cell growth.
Our services
1. Supply top quality products with a reasonable price.
2. Arrange the orders and shipping with your requests on time, According to the different countries export policy provide complete customs clearance documents.
3. Samples can be arranged for testing and Unconditional assume responds.
4. Provide a price trend, ensure the clients can know about marketing informations in time.
Packing and Shipping:
| Product name | Trametinib |
| CAS NO. | 871700-17-3 |
| Synonyms | (GSK1120212) |
| Category | Pharmaceutical Raw Materials,Active Pharmaceutical Ingredients,Bulk Drugs,Fine Chemicals. |
| Purity | 99% Trametinib |
| Appearance | Trametinib powder |
| Shelf life | 2 years |
| Usage | Trametinib is an anti-cancer drug. |
| Storage | Trametinib should be stored in a well-closed container at low temperature, keep away from moisture, heat and light. |
| Note | Trametinib for R&D use only. |
Function
Trametinib, also known as GSK1120212, is a n orally bioavailable inhibitor of mitogen-activated protein kinase kinase (MEK
MAPK/ERK kinase) with potential antineoplastic activity. Trametinib specifically binds to and inhibits MEK 1 and 2, resulting in
an inhibition of growth factor-mediated cell signaling and cellular proliferation in various cancers. MEK 1 and 2, dual
specificity threonine/tyrosine kinases often upregulated in various cancer cell types, play a key role in the activation of the
RAS/RAF/MEK/ERK signaling pathway that regulates cell growth.
Our services
1. Supply top quality products with a reasonable price.
2. Arrange the orders and shipping with your requests on time, According to the different countries export policy provide complete customs clearance documents.
3. Samples can be arranged for testing and Unconditional assume responds.
4. Provide a price trend, ensure the clients can know about marketing informations in time.
Packing and Shipping:
